Left ventricular hypertrophy in hypertension as a predictor of coronary events: Relation to geometry

Current Opinion in Nephrology and Hypertension

Volumn 11, Issue 2, 2002, Pages 215-220

  De Simone, Giovanni ^a   Palmieri, Vittorio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CORONARY HEMODYNAMICS; CORONARY RISK; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

CORONARY DISEASE; ECHOCARDIOGRAPHY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; PROGNOSIS;

EID: 0036191162     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200203000-00013     Document Type: Review

References (63)

1. Interaction between body size and cardiac workload: Influence on left ventricular mass during body growth and adulthood
2. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study
3. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
4. Prognostic value of serial changes in left ventricular mass in essential hypertension
5. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events
6. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease
7. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass
8. Association of carotid atherosclerosis and left ventricular hypertrophy
9. Left ventricular mass as a measure of preclinical hypertensive disease
10. Imaging techniques for non-invasive assessment of coronary heart disease in hypertension: Value of an integrated approach
11. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight
12. Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk
13. Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: The RES trial. Reliability of M-mode Echocardiographic Studies
14. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension
15. Prognostic implications of left ventricular hypertrophy
16. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy
17. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease
18. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease
19. Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension
20. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed
21. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy
22. Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction
23. Metabolic risk factors and left ventricular hypertrophy
24. Relation of fibrinogen to cardiovascular events independent of preclinical cardiovascular disease. The strong heart study
25. Left ventricular hypertrophy associated with hypertension and its relevance as a risk factor for complications
26. Systemic hypertension and coronary artery disease: The link
27. State of the Art lecture. Risk mechanisms in hypertensive heart disease
28. Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study
29. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension
30. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy
31. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy
32. Remodelling of microvessels by coronary hypertension or cardiac hypertrophy in rats
33. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve
34. Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients
35. Coronary vascular changes in the progression and regression of hypertensive heart disease
36. Alterations in the coronary circulation in hypertrophied ventricles
37. Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease
38. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle
39. Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide
40. Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: Comparison with subjects with insulin resistance syndrome and normal controls
41. Coronary vascular mechanisms involved in decompensation from hypertrophy to heart failure
42. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: A prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test
43. Evaluation of coronary flow reserve in hypertensive patients by dipyridamole transesophageal doppler echocardiography
44. Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy
45. Relation of left ventricular diastolic properties to systolic function in arterial hypertension
46. Abnormal coronary flow dynamics at rest and during tachycardia associated with impaired left ventricular relaxation in humans: Implication for tachycardia-induced myocardial ischemia
47. The effect of acute changes in coronary blood flow on left ventricular end-diastolic wall thickness. An echocardiographic study
48. Left ventricular hypertrophy and diastolic dysfunction: Their relation to coronary heart disease
49. Relation between diastolic left ventricular function and myocardial blood volume during adenosine-induced coronary hyperemia
50. Prolonged diastolic time fraction protects myocardial perfusion when coronary blood flow is reduced
51. Effects of coronary blood flow on left ventricular function in essential hypertensive patients
52. Deterioration in peak systolic velocity is closely related to ischaemia during angioplasty: A vectorcardiographic and tissue Doppler imaging study
53. Is insulin action a determinant of left ventricular relaxation in uncomplicated essential hypertension?
54. Left ventricular diastolic filling dynamics during isometric exertion in syndrome X assessed with Doppler flowmetry
55. Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity
56. Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics
57. Overview of hemodynamic and non-hemodynamic factors associated with left ventricular hypertrophy
58. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy
59. Left ventricular hypertrophy, myocardial blood flow and coronary flow reserve
60. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension
61. Structural basis for pathologic left ventricular hypertrophy
62. Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: In vivo and in vitro studies on collagen matrix regulation
63. Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: Role of TGF-beta(1)